விசுவாசமான பள்ளத்தாக்கு மூலதனம் News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from விசுவாசமான பள்ளத்தாக்கு மூலதனம். Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In விசுவாசமான பள்ளத்தாக்கு மூலதனம் Today - Breaking & Trending Today

VC Daily: Venture Capitalists Push Back Against Drug-Pricing Bill

VC Daily: Venture Capitalists Push Back Against Drug-Pricing Bill
morningstar.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from morningstar.com Daily Mail and Mail on Sunday newspapers.

New South Wales , United Kingdom , Al Iskandariyah , United States , City Of , Noord Holland , Walnut Creek , Santa Monica , North Lanarkshire , Maple Grove , Vanqua Bio , Wouter Verhoeven , Peter Kolchinsky , Arjun Goyal , Chan Lee , Chris Dattaro , Lina Khan , Andreessen Horowitz , Jim Trenkle , Aspen Rxhealth , Jesse Hall , Roche Genentech , Karen Walker , John Stanford , Keno Gutierrez , Chris Cumming ,

China's genome editing startup EdiGene nets $62m in Series B+ round


Photo: Pixabay
April 22, 2021
Chinese genome editing startup EdiGene Inc has secured 400 million yuan ($61.7 million) in a Series B+ round of financing led by private equity (PE) firm Loyal Valley Capital to advance its pipeline into clinics and to scale up the business operation.
The Series B+ round roped in new investors BioTrack Capital and Sherpa Healthcare Partners, two China-focused, healthcare venture capital (VC) companies. The firm’s existing investors including IDG Capital, Lilly Asia Venture, 3H Health Investment, Huagai Capital, Sequoia Capital China, Alwin Capital, and Kunlun Capital re-upped in the deal.
Founded in 2015, EdiGene is a clinical-stage biotech company that focuses on leveraging genome editing technologies to accelerate drug discovery and to develop novel therapeutics for a broad range of genetic diseases and cancer. The startup has established its proprietary  ....

United States , Asia Pacific , Randy Lin , China National Medical Products Administration , H Health Investment , Edigene Inc , Loyal Valley Capital , Biotrack Capital , Sherpa Healthcare Partners , Lilly Asia Venture , Health Investment , Huagai Capital , Sequoia Capital China , Alwin Capital , Kunlun Capital , North America , Drug Evaluation , National Medical Products Administration , Investigational New Drug , ஒன்றுபட்டது மாநிலங்களில் , ஆசியா பெஸிஃபிக் , ஆண்டி லின் , ஏச் ஆரோக்கியம் முதலீடு , விசுவாசமான பள்ளத்தாக்கு மூலதனம் , ஷெர்பா சுகாதாரம் கூட்டாளர்கள் , லில்லி ஆசியா துணிகர ,